Background

Matt is a Partner at TCV leading the firm’s infrastructure software investing efforts. He joined the firm in 2011 as an Associate supporting TCV’s healthcare IT and services investment efforts from New York and Palo Alto. Matt is actively involved in TCV’s investments in Aviatrix, Devo Technology, HashiCorp (NASDAQ: HCP), OneTrust, Vectra, and Venafi. His prior investments include Cradlepoint (acquired by Ericsson) and Silver Peak (acquired by HPE).

Before TCV, Matt was an analyst in the Global Healthcare Group at UBS Investment Bank in New York, advising healthcare clients on a range of transactions spanning M&A, equity, and debt offerings. Matt also previously spent time evaluating healthcare investment opportunities at General Atlantic in New York.

Interests

Born and raised in a small town in southern Indiana, Matt always dreamed of seeing and learning as much about the world as he could.  Moving to New York after college was the first step. Since then, he’s traveled to more than 20 countries and spent the summer after earning his M.B.A. interning at one of the world’s leading vineyards, Château Margaux, in Bordeaux and Paris. Outside of travel, food, and wine, Matt enjoys reading, fitness (Jess King and Alex Touissant on Peloton), and modern art. Matt is an avid supporter of New York based art museums and LGBTQ+ non-profits.

Education
Matt received his M.B.A. from Harvard Business School and graduated with a B.S. in Biochemistry with honors from Indiana University.